Worcester Business Journal Special Editions

Central MA Life Sciences Report

Issue link: https://nebusinessmedia.uberflip.com/i/1496515

Contents of this Issue

Navigation

Page 29 of 39

30 Central MA Life Sciences Report Companies with the most Central Mass. life sciences patents When the U.S. Patent and Trade Office assigns a patent, its location is determined by the residence of the first-name inventor. Of the 649 life sciences patents assigned to Central Massachusetts inventors from 2018 to 2022, these companies had the most patents. ASSIGNEE (COMPANY OR ORGANIZATION) TOTAL Modernatx, Inc. (Moderna), Cambridge 42 Acceleron Pharma Inc., Cambridge 30 Sage Therapeutics, Inc., Cambridge 29 Sunovion Pharmaceuticals Inc., Marlborough 29 President And Fellows Of Harvard College, Cambridge 23 Abbvie Inc., Worcester 20 Lantheus Medical Imaging, Inc., Billerica 20 Immunogen, Inc., Waltham 19 Genzyme Corp., Cambridge 18 Phio Pharmaceuticals Corp., Marlborough 18 Alkermes Pharma Ireland Limited, Waltham 17 Pfizer Inc., Cambridge 16 Bioverativ Therapeutics Inc., Cambridge 15 The Trustees Of The University Of Pennsylvania 15 Biogen MA Inc., Cambridge 13 MacFarlan Smith Limited, Scotland 13 Kura Oncology, Inc., Boston 12 Astellas Institute For Regenerative Medicine, Westborough 11 Dicerna Pharmaceuticals, Inc., Lexington 10 Enanta Pharmaceuticals, Inc., Watertown 10 Massachusetts Institute Of Technology, Cambridge 10 Merck Patent Gmbh, Burlington 10 Celgene Car Llc, Devens 9 Proteostasis Therapeutics, Inc., Boston 9 Synlogic Operating Company Inc., Cambridge 9 Dana-Farber Cancer Institute, Inc., Boston 8 Syndevrx, Inc., Cambridge 8 Beth Israel Deaconess Medical Center, Boston 7 Mersana Therapeutics, Inc., Cambridge 7 The Brigham And Women's Hospital, Inc., Boston 7 Amgen Inc., Cambridge 6 Bristol-Myers Squibb Co., Devens 6 ASSIGNEE (COMPANY OR ORGANIZATION) TOTAL Forma Therapeutics, Inc., Watertown 6 Idera Pharmaceuticals, Inc., Cambridge 6 Ixcela, Inc., Bedford 6 Signablok, Inc., Shrewsbury 6 Suragani, Rajasekhar Naga Venkata Sai, Wrentham 6 Syros Pharmaceuticals, Inc., Cambridge 6 Takeda Pharmaceutical Co. Limited, Cambridge 6 Agios Pharmaceuticals, Inc., Cambridge 5 Alzheon, Inc., Framingham 5 Bayer Pharma Aktiengesellschaft, Cambridge 5 Boston Scientific, Inc., Marlborough 5 Lennham Pharmaceuticals, Inc., Concord 5 The Broad Institute Inc., Cambridge 5 Covidien LP, Mansfield 4 DOTS Technology Corp., Natick 4 Life Technologies Corp., Framingham 4 Proclara Biosciences, Inc., Cambridge 4 Qiagen Sciences, LLC, Maryland 4 Blueprint Medicines Corp., Cambridge 3 Infinity Pharmaceuticals, Inc., Cambridge 3 Karyopharm Therapeutics Inc., Newton 3 Merck Sharp & Dohme LLC, Boston 3 Millennium Pharmaceuticals, Inc., Cambridge 3 Mitobridge, Inc., Cambridge 3 Morphic Therapeutic, Inc., Waltham 3 Novo Nordisk Health Care, New Jersey 3 Selecta Biosciences, Inc., Watertown 3 Siemens Healthcare Diagnostics Inc., Germany 3 The General Hospital Corp., Boston 3 Note: 2022 figures are preliminary. Source: U.S. Patent and Trade Office (U.S. PTO)

Articles in this issue

Archives of this issue

view archives of Worcester Business Journal Special Editions - Central MA Life Sciences Report